ATLASATLAS fair value
ATLAS has no fair value for this stock today.
PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NASDAQ
$19.80▼ -0.15%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on PROCEPT BioRobotics in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On PROCEPT BioRobotics
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives PROCEPT BioRobotics a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $17.51 and $21.88; in 9 out of 10, between $14.38 and $26.65. Estimated annual volatility is 66%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $983M
- 52-week high
- $38.11
- 52-week low
- $16.67
- Revenue (12 months)
- $337M
- Revenue growth (YoY)
- +37.2%
- Gross margin
- 63.7%
- Operating margin
- -33.7%
- Net margin
- -31.0%
- Return on equity
- -30.2%
- Free cash flow (12 months)
- $-49.0M
- Beta
- 0.90
What this means
ATLAS does not publish a fair value for PRCT right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks PRCT has traded between $16.67 and $38.11. Today it is 48.1% below that high and 19% above its low.
On the business: revenue grew 37.2% year over year; net margin is 31.0%.
Its beta is 0.90: it moves roughly in line with the market.
About the company
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company focused on urology. The company develops, manufactures, and sells the AquaBeam Robotic System and the HYDROS Robotic System, both designed for image-guided, minimally invasive urologic procedures.
Want to see everything about PROCEPT BioRobotics?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does PROCEPT BioRobotics do?
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company focused on urology. The company develops, manufactures, and sells the AquaBeam Robotic System and the HYDROS Robotic System, both designed for image-guided, minimally invasive urologic procedures.
What is the chance PRCT goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, PRCT ends the month between $17.51 and $21.88.
How big is PROCEPT BioRobotics and what is its P/E ratio?
PROCEPT BioRobotics's market capitalization is $983M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is PRCT?
ATLAS estimates annual volatility at 66%. In a typical month, half of the outcomes end between $17.51 and $21.88.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer